When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Content provided by Audioboom and Applied Clinical Trials. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Applied Clinical Trials or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
ACT Brief: Smarter Study Planning, New AML Approval, and Biomarker Gaps in Cancer Care
MP3•Episode home
Manage episode 519902824 series 3665342
Content provided by Audioboom and Applied Clinical Trials. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Applied Clinical Trials or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In today’s ACT Brief, we look at how real-world data and AI are helping prevent costly study rescue, review the FDA’s approval of a first-in-class menin inhibitor for NPM1-mutated AML, and explore new insights on closing biomarker-testing gaps in oncology.
101 episodes
MP3•Episode home
Manage episode 519902824 series 3665342
Content provided by Audioboom and Applied Clinical Trials. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Applied Clinical Trials or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In today’s ACT Brief, we look at how real-world data and AI are helping prevent costly study rescue, review the FDA’s approval of a first-in-class menin inhibitor for NPM1-mutated AML, and explore new insights on closing biomarker-testing gaps in oncology.
101 episodes
Semua episod
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.